S S A R

28th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE

Programme

28th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE

The full programme can be downloaded in pdf by clicking here

 

Friday, April 8th, 2022

 

Posters are displayed in “Lille Sal”. Posters should be in place before 9.00 and removed after the last poster session of the day. You should be present at your poster during all poster sessions of the day. Your poster should be placed on the board with your number on.

Session IV. CASRIOVASCULAR DISEASE

No 27

Female patients with familial hypercholesterolemia have higher cholesterol burden at 19 and 30 years of age: data from 12-years follow-up.
Kirsten Holven (Norway)

No 28

Elevated remnant cholesterol appropriately reclassifies individuals who develop myocardial infarction
Takahito Doi (Denmark/Japan)

No 30

The Lp(a) equivalent to FH in ASCVD risk: CGPS
Berit Storgaard Hedegaard (Denmark)

No 33

Familial Hypercholesterolemia prevalence among ethnicities – systematic review and meta-analysis
Frida Toft-Nielsen (Denmark)

15.15 – 16.00:

YIA Poster Walk . Selected abstracts (3 min presentation + 2 min discussion)

No 29

Viral transgene delivery to endothelial cells in mouse models
Jannik Hjortshøj Larsen (Denmark)

No 31

Unraveling macrophage heterogeneity in human atherosclerosis
Elias Wieland (The Netherlands)

No 34

A Trojan horse in contrast-enhanced MRI? Superparamagnetic iron oxide nanoparticles enhance apoptosis in human and murine atherosclerosis
Adele Ruder (The Netherlands)

No 38

Severe a1-antitrypsin deficiency associated with increased risk of heart failure in two large populations
Sine Voss Winther (Denmark)

No 41

ApoB and non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk
Camilla D. L. Johannesen (Denmark)

No 42

ApoM is associated with prevalent cardiovascular disease in patients with chronic kidney disease
Sarunja Vijayakumar (Denmark)

No 48

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomized ASSAIL-MI trial
Camilla Huse (Norway)